U.S. Department of Commerce Finds Subsidies in Glycine Imports from India

Estimated reading time: 3–5 minutes

Date: 2026-09-14

Introduction

The U.S. Department of Commerce (Commerce) has made a preliminary decision about glycine products imported from India. They think that some companies in India received unfair money help from their government, which makes selling their products cheaper in the U.S. This is part of an ongoing investigation to make sure trade rules are fair.

Background

Glycine is a product that the U.S. monitors closely. In 2019, a rule was set to make sure India was not giving unfair help to their companies for glycine. Commerce has done a review for the year 2024 to check if these rules were followed. They started this talk in July 2025 and chose two main companies, Kumar Industries and Mulji Mehta Enterprises, to look at closely.

Decision to Rescind for Some Companies

Commerce has decided to stop looking at 27 companies because nobody wanted a review for them anymore. This means those companies will not be part of this decision about unfair subsidies.

Reason for the Review

A review is done to make sure there are no unfair practices. The U.S. laws state there should be no unfair help from governments to companies that could harm fair trade. Commerce found that some companies may have received help, which means they sold glycine at lower prices unfairly.

Results and Method

For this review, Commerce found that Kumar Industries and Mulji Mehta Enterprises took part in these programs. They gave Kumar a subsidy rate of 39.75% and Mulji Mehta Enterprises a rate of 104.92%. Mulji Mehta Pharma, linked to Mulji Mehta Enterprises, also got Kumar’s rate of 39.75% because it wasn’t separately checked.

What Happens Next?

Commerce will allow people to talk about this decision before making it final. Anyone interested in giving thoughts must do so within 21 days from today’s announcement. The final decision will be made after listening to these comments.

Conclusion

This step ensures fair trade practices between the U.S. and India concerning glycine. Commerce’s actions aim to protect U.S. businesses from unfair competition while ensuring they follow international trade rules. Families and industries relying on fair pricing will be kept informed as the review continues.

For more detailed information, parties are invited to access the full preliminary review memorandum online.


Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.